About the trial

Staphylococcus aureus bloodstream infection is one of the most serious bacterial infections worldwide, requiring intravenous antibiotics and weeks of hospitalisation. SNAP (Staphylococcus aureus bacteraemia Network Adaptive Platform) will evaluate combinations of antibiotics and interventions aimed at reducing mortality, decreasing time spent in hospital and improving long-term health outcomes in people with this infection.

About the software

This is Spinnaker, a user friendly, bespoke application that helps researchers find answers to important medical questions. The team behind the platform can adapt the software to match your study and we are especially interested in doing this for novel trials.

Spinnaker is a cloud based, integrated software/database solution for randomising patients using any design methodology including response adaptive methods; backed up by an electronic data capture application that is intuitive and particular. The application also includes management functions to alert relevant people about events (e.g. SAE), to manage drug inventory and to report on progress.

You can read more on the Spinnaker website or contact Audrey on [email protected]

You can get to know us a little better through our blog and social media pages accessed via the logout screen of this trial.

Made with love in New Zealand.